Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
News|Articles|January 1, 2005
Pharmaceutical Technology Europe
- Pharmaceutical Technology Europe-01-01-2005
- Volume 17
- Issue 1
Issues in the Appraisal of Laser Diffraction Particle Sizing Techniques
Author(s)Paul Kippax
Laser diffraction is an important technique for particle size analysis. This article highlights the many advantages this tool has to offer.
Advertisement
Articles in this issue
almost 22 years ago
Dessicants for Pharmaceutical Applicationsalmost 22 years ago
US Packaging Show Displays many Pharma Machinesalmost 22 years ago
The Seventh Annual International Employment Surveyalmost 2022 years ago
The Use of Acrylic Resins for Improved Aqueous Enteric CoatingAdvertisement
Related to this article
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Episode 1, Part 3 of PharmTech AI Pulse Check covers why INTerpath-001's AI isn't ChatGPT and names pharma manufacturing's biggest AI governance gaps.
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.
FDA approves tavapadon, first D1/D5 agonist, validating AbbVie's $8.7B Cerevel deal and an October five-strength oral tablet launch.
Advertisement
Advertisement